Creation
Draft
Initial
Detailed
Accepted
Adoption
Idea Description
Supplementary Information
Innovation 'Elevator Pitch':
Incredible amounts of expensive drugs are thrown away by pharmaceuticals companies, health trusts & GP surgeries due to refrigeration problems. Everyware technology enables remote data monitoring & intervention for pharmaceutical & food storage
Overview of Innovation:
The problem. Correct handling and storage of drugs and medicines is critical in ensuring that they remain functional and safe to use. Regular monitoring and data capture highlights trends and issues not evident from manual record keeping. Over weekends and during holiday periods readings may not be recorded. Failure of a refrigerator or break in power supply could render contents unusable or remain undetected
 
EveryWare has developed an intelligent software platform with smart sensors, integrated and modular, in conjunction with clinicians to tackle this major problem. Local devices monitor a range of parameters, including ambient temperature, pressure and humidity; together with refrigeration temperatures at different levels within each unit
 
Local and remote alerts can be triggered when your own defined rules are breached. Alerts may be visual and audible in a monitored location with users receiving direct notifications via email, SMS and other channels. Data is visualized and accessible on computers, tablets and smartphones
 
Testimonial
Clinical bodies and Trusts’ guidelines require regular monitoring of critical storage temperatures. Legislation requires that records are kept and this is often a manual task with readings taken at up to 24 hour intervals
 
Successful trials yielded a wealth of information for pharmacy staff to gain immediate, real time insight into how efficient their refrigerators are and how ambient conditions and working practices affect them. Clinicians benefit from the reduced workload and the availability of high resolution data proves compliance with healthcare guidelines 24/7

Differences between types of refrigerator become evident. Recovery time following prolonged periods of access can expose the contents to raised temperatures for longer; trend data clearly demonstrates the effects of daily routines and identifies opportunities for training that will improve the safe storage and dispensing of critical medicines
 
EveryWare’s unique modular system means that the unit cost of the sensors is low. All other costs are capped, so no need to worry about data rates and variable costs. Annual cost of the system is a fraction of the cost of the assets or processes being monitored. System is designed from the ground up to be completely user-configurable to suit local and business requirements. Security is paramount; all cloud systems and data are network-isolated, multiple-passkey protected with encrypted communications.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Similar Content3
Innovation 'Elevator Pitch':
CheckWare for digital clinical assessment & remote patient monitoring in Mental Health, Physical Health and Long-Term conditions. Automates the delivery, scoring, comparison and reporting of over 1,200 authorised assessments (all IAPT)
Overview of Innovation:
CheckWare – a brief summary
 
  • CheckWare is for Healthcare organisations that want to offer secure, digital clinical assessment and remote patient monitoring in Mental Health, Physical Health and Long-Term conditions
 
  • CheckWare delivers secure eHealth solutions that automate the delivery, scoring, comparison and reporting of over 1,200 authorised clinical assessments and tests. (including all IAPT assessments)
 
  • CheckWare makes it possible for patients to participate digitally in their own treatment through self-reporting.
 
  • By replacing paper-based procedures, CheckWare securely increases treatment efficiency and proves clinical outcomes
 
  • CheckWare is the only solution for the digital automation of clinical assessment and PROM and to have the digital rights to over a thousand clinical assessment tests and outcome measures.
 
  • CheckWare digital assessment tests and questionnaires are already used within a clinical environment, community or clinical research.
 
  • The data collected is automatically and immediately available for clinical, patient or research reporting and feedback and for proof of outcome measures.
 
  • CheckWare can, where appropriate, empower the patient (or parent) to “self-report” between clinical appointments – allowing clinicians to prioritise waiting lists or be automatically informed of any patient health changes or deteriorations.
 
  • CheckWare provides the ability to create assessment pathways to reflect working processes, and to assist in patient interaction.
 
  • Additionally, CheckWare can be used to automatically set goals, provide reminders, feedback and content (text, video, URL etc).
 
  • The CheckWare system has a secure open API (Application Program Interface) – and has been integrated into multiple different EPR and PAS systems
 
  • Aggregated data can be exported from the system for either reporting or research (SPSS format if required) – or could be viewed on the on-line clinical dashboards
 
  • The CheckWare system is secure - compliant with HL7 and with IG / NHS Toolkit standards and resides on the N3 NHS Network.
 
  • CheckWare has been licenced in multiple NHS organisations and in over 360 organisations throughout Europe.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Prove outcome measures through aggregated data, reduce use of paper based assessment tests, automatically score and report at point of care, prioritise waiting lists, automatically alert and react to patient health changes. prevent unnecessary clinical appointments, automate any royaly payments due.
Initial Review Rating
4.40 (2 ratings)
Benefit to WM population:
Prove outcome measures through aggregated data, reduce use of paper based assessment tests, automatically score and report at point of care, prioritise waiting lists, automatically alert and react to patient health changes. prevent unnecessary clinical appointments, automate any royaly payments due.
Current and planned activity: 
Already engaged (in a small way) with the NHS - need assistance to broaden our engagement and customer base a
What is the intellectual property status of your innovation?:
IP is wholly owned by CheckWare
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
Protect people with dementia from unattended falls, dehydration, malnutrition and hypothermia by hourly checking patterns of normal activities in their kitchens. 
Overview of Innovation:
Many older people want to live independently for as long as possible, causing anxiety for family and friends.  They are often in denial of their declining capacity, proud and won’t wear pendants.  With impaired cognition, many suffer from unattended falls, dehydration, malnutrition or hypothermia.  They are admitted to hospital needing longer treatment for poorer health outcomes and greater risk of transfer into a care home. 

To make sure that service users are moving around as normal, drinking, eating and warm, Kemuri checks every hour.  It alerts families and carers of important changes and provides valuable details for guiding action.  Peace of mind results in better outcomes and reduced costs for everybody.

Kemuri does not stigmatise because it looks a familiar Power Socket to the service user.  There’s nothing to remember and people continue with normal activities such as boiling kettles and heating food in microwaves or other electrical equipment.


KemuriSense® mains Smart Power Sockets continuously monitor motion, power usage, temperature and humidity and send data via GSM mobile phone signals to the Internet.  Mains power loss is automatically reported whilst it continues to report other sensor readings.  

The Wellbeing Monitor App informs families and carers of older vulnerable people who:
  • Want to live independently
  • Reject or forget pendant alarms
  • Deny declining capacity
  • Show symptoms of dementia
  • Remove things they don’t understand
  • Need daily monitoring 


Predictive analytics check every hour for changes to patterns of motion and power usage.  If there are many changes, then alerts may be sent to families, carers or 24/7 response centres.

As stated by a Commissioning Manager at a County Council, “ ... this is a unique product ….  I think there’s potential here for both self funder and LA funding as a potential option that fills a gap that conventional telecare does not.”
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
Dementia is increasing in the population. Kemuri is a tool for stabilising the wellbeing of older people living alone who are declining in their ability to undertake Activities of Daily Living. Better wellbeing means healthier people, better health outcomes & more efficient use of NHS resources. Institute of Ageing research shows a range of pathways that people take before they are unable to live independently.


Early intervention is proven to reduce costs significantly. Kemuri should be deployed as soon as people are showing early symptoms of dementia. With loss in mobility, falls are inevitable: half those 80+ fall at least once p.a. Falls cost the NHS £2bn p.a. People with dementia tend to forget their pendant alarms/wearable telecare devices. If unable to call for help they may suffer for days before discovery & admission to A&E with medical complications. Kemuri’s hourly analysis of patterns of motion power usage automatically alerts to the risk of unattended falls.

In comparison pendant alarms are ineffective with early stage dementia. Out of 1.6m issued 32% are never worn & only 8% are worn all the time as prescribed. 500,000 unworn pendant alarms waste as much as £80m p.a. Kemuri continuously monitors motion, learns patterns of activity without any cognitive input from the service user.


A value to the NHS of early A&E admission into hospital is better health outcomes & more people discharged back to independent living on average after 12.3 days (discharge to residential care on average 31.7 days, 2.5 times longer).



£5000 could be re-allocated for each episode avoiding discharge to a care home. Unattended falls longer than 24 hours result in stabilisation time, longer treatment & delayed transfers of care. Kemuri preventive telecare with a wellbeing monitor & daily attention will also help to minimise the number of patients suffering the effects of hypothermia, dehydration & malnutrition.
  • Cold homes cost the NHS in England more than £1.36bn p.a.
  • Dehydration complications include low blood pressure, weakness, dizziness, increased risk of falls, & pressure sores
  • Malnutrition costs the NHS £7bn p.a. Risk (in 2010) was 28% in patients < 60 years, 32% 60-79 years & 44% if > 80 years
Kemuri could be funded by the NHS for a few weeks after discharge on the grounds that people admitted in a healthier state are less complex to treat, have improved health outcomes & are less likely to be readmitted, with the ongoing service funded by Social Services or self-funders.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
West Midlands has a population of 5.6 million people covering an area of more than 5,000 square miles.  It is a region full of contrasts and diversity.  It includes the second largest urban area in the country (Birmingham, Solihull and the Black Country) yet over 80% of the area is rural.  It is the second most ethnically diverse region in the country after London.  There are probably 40,000 older people who might be suitable for passive wellbeing monitoring.  Many of these are admitted to hospital and may not be able to return to their own homes. 

Older people are at the focus of Kemuri wellbeing monitoring.  Hourly and daily pattern analysis reduces risk and extends the period that they can continue to live independently at home.  Everybody has access to information that reduces the risk of unattended falls, dehydration, malnutrition and hypothermia.  Alerts are automatic without older people having to change their life style.  A familiar power socket is not stigmatising or intrusive.  There are no wearable devices to remember or unfamiliar sensors to be discarded.  Discharge from hospital could be accelerated with a KemuriSense Power Socket pre-installed.

Families and carers use the Wellbeing App for peace of mind.  At any time of day, from anywhere in the World, people can view the changes to patterns of behaviour.  There’s an option to receive alerts after more changes than usual.  They can enquire about wellbeing with full knowledge of the predictive analysis and decide on appropriate action. Some of the tragic outcomes of unattended falls are avoidable with hourly monitoring.  Additionally, it’s possible to confirm that domiciliary carers have provided drinks and meals at the time they were ordered.

Service organisations benefit from accurate data.  Sheltered housing wardens, domiciliary care providers and alarm response centres have full access to the Wellbeing Monitor and can prioritise their care calls.  Kemuri is efficient to deploy.  The portable model is operational in ten seconds with no skill required.  The fixed model can be installed and tested within 15 minutes.  There are no rules to enter because the system learns patterns of activity.  Alerts are automatically sent to response centres or users of the app.  
Current and planned activity: 
Manufacturing batches of 100 units for trials/sales to housing associations/telecare service providers. First trials are in sheltered accommodation in County Durham in conjunction with Durham University (part of EU funded Erasmus+ project)

Controlled clinical trials required to collect evidence to support the benefits claimed (reducing impact of falls). Sample sizes to account for significant number of subjects continuing to live normally without any falls requiring intervention. Access to medical records/cost of treatment/health outcomes/discharge data/subsequent care pathways required

Kemuri collects accurate lifestyle data that can be used in clinical trials of drugs dispensed to people living independently including people with cognitive impairment/physical disability not able to record times of events/ambient conditions. KemuriSense power sockets can collect data for several years, in dementia trials it may be possible to identify rates of decline & use it to modify the care regime
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 

Note that the patent applies to more devices than a power socket.  It covers the internal electronics and components, which could be incorporated into any equipment consuming significant amounts of power. 

Kemuri and KemuriSense are registered trademarks.  
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
3
Regulatory Approvals:
The KemuriSense Smart Power Socket has been tested for EMC (Electro Magnetic Compliance) and CE certification. 

The product only measures ambient conditions and does not require certification as a medical device.
Commercial information:
We are building batches of 100 for field trials with availability in January 2017. 

The projected sales shown in the table below.



The growth accelerates as more telecare resellers become customers.

Current and potential telecare users: The Strategic Society Centre undertook a major quantitative research project entitled Who uses telecare? published in 2012 to explore usage of telecare among older people in England and identify potential users of telecare. It provided a conservative estimate based on 2008 data that among the over-50s in England, there were well over 1 million telecare users. However, by mapping individuals with similar conditions, the report was able to identify around 2.5 million more individuals living alone who may be able to benefit from telecare, and potentially as many as 4.1 million with conditions that could merit the use of telecare.

Further, the report stated that around 30% to 50 % of current telecare users paid for their telecare themselves or with the help of a family member. Among private and non-privately funded telecare users, it appears there is little difference in incomes. This suggests that relatively low income is not a barrier to individuals and their families funding telecare themselves or that most users can contribute to the cost of telecare support.
The report made recommendations to policymakers to aim to boost the usage of telecare to at least double current prevalence focusing on individuals living alone. It also recommended that policymakers and the industry should focus on targeting informal carers, including both cohabiting and non-cohabiting family carers as potential beneficiaries of greater usage of telecare.

Global telecare market: The global telecare market is valued at c. £1 billion per annum and is forecast by the Deloitte Centre for Health Solutions to grow at a rate of 5% per annum from now to 2018. The factors contributing to growth and market attractiveness are related to government initiatives and funding and the public willingness and receptivity towards technological advancement. The UK is the leading market for telecare products and services, with the UK telecare market share of up to 25% of the global market. Other prominent markets for telecare in terms of ageing populations that demand such services include France, Italy and Benelux (comprising Belgium, Luxemburg and the Netherlands).

Ireland, Malta, Singapore, Hong-Kong, Malaysia and Saudi Arabia as potential overseas markets for KemuriSense®, as those territories use British standard socket outlets.
Investment activity:
Kemuri was founded by Dr Leonard Anderson, Russell Anderson and Michael Anderson in January 2014.  Together, they worked on the concept for an older person’s carer assistance solution after failing to find a suitable product and service on the market.  The Company’s activity to date has been focused on product and web-services development and has been funded from private and public sources.  Kemuri’s proof-of-concept project was successfully completed in October 2015, assisted by grants from Innovate UK; £66,734 for a Smart Grant and £5,000 for a Smart Voucher. A £2,000 prize from Kent County Council paid for the first smart power socket prototype. 

Dr Anderson has provided an unsecured director's loan facility of £100,000.

Innovate UK sponsored £5000 research with the Institute of Ageing at Newcastle University for the Ethics of Passive Monitoring.

The company raised £545,000 in a private offer via West Hill Capital.  The funds are being deployed to refine the core product infrastructure, to develop the mobile app, to recruit staff across operations and to build an online sales platform. 

Kemuri has been awarded with €100,000 as a partner in an Erasmus + project for people-centred centred design.  Our UK partner is Durham University together with others in Netherlands, Czech Republic and Slovenia

The Company is a growth business and will not be cash generative in the short term as it invests heavily in developing the business in order to generate long-term profitable business relationships.

A key requirement is to find funding for an academic study to collect evidence for the value of predictive analytics for a period of at least one year.  Grants are being sought from multiple sources.
Regional Scalability:
Smart power socket production is scalable (batches of 100-1000 p.m) in the Woking production facility (larger volumes achieved by second sourcing manufacture). The Web technology is cloud-based & can be rapidly scaled by commissioning more servers/storage at short notice. WM scale-up can be generated by raising awareness with the following:
  • Social Services Commissioners/OTs
  • GP Surgeries, Mental Health & Hospital Trusts
  • Housing Associations & Voluntary Sector eg AgeUK
  • Telecare Service Companies
  • Local media/online sales websites 
Welbeing, our telecare service partner’s clients include WM local authorities & housing associations, providing installation & call monitoring services to any new customers in the region.

As a start-up our effort is directed to delivering reliable hardware & software with small sample numbers. Our design objective is for KemuriSense power sockets to operate continuously for at least 5 years. First trials have started in County Durham housing associations.
Measures:
In co-operation with an academic research partner, we hope to achieve the following in a trial:

Quality
  • Continuous reliable operation
  • Avoidance of false alerts
  • Recognising unattended falls, strokes or other episodes that result in a carer taking action that saved time and cost for medical intervention.
  • Peace of mind achieved for families and carers
  • Identifying trends that indicate the risk of hypothermia, dehydration and malnutrition.
  • Identifying activity at unusual times of day that lead to helpful family or medical intervention 
Safety
  • Electrical safety of products after installation in kitchens.
  • Security of personal data and avoidance of data loss. 
Cost
The trial budget is £500,000.  This would include the costs of selection, installation, monitoring, service support and surveying families throughout the trial.  Note that his includes detailed data analysis, medical services, the final report and communications.
 
People
The target group for research is a cohort that has these attributes:
  • Reject pendant alarms
  • Deny declining capacity
  • Want to live independently
  • Show symptoms of dementia
  • Need daily monitoring
A percentage will be used as a control group who are not included in the Trial.  The total numbers are to agreed by the academic research partner from one of the West Midlands universities.
 
Ethics
Finding volunteer older people and their next of kin will require access to the medical records and adult social care records of older people living alone.  This will also be needed during the trial to measure the times and costs of medical treatment.  Approval by the Ethics Committee will be required.  
Adoption target:
Assuming that there are 500,000 unused pendants in the UK, there are approximately 40,000 candidates for Kemuri wellbeing monitoring in a West Midlands population of 5 million.   

500 is a reasonable target for 2017/2018 – with an possibility of growing to 10,000 in 5 years.  
Investment sought:
A total investment of £500,000 over two years would provide a trial that provides evidence for wider adoption in the Region.  For budgeting purposes, this breaks down as follows:
  • £40,000 - Project Management
  • £100,000 – Installation and Web services for 120 older people and their families
  • £50,000 – Health service costs
  • £250,000 – Academic research costs
  • £60,000 – Kemuri cost to support the trial. 
The findings should be applicable throughout the UK. 

The objective is to obtain SBRI funding for the project.  
Read more
Hide details
Innovation 'Elevator Pitch':
Kemuri portable K-Sockets have a 500% return on investment in one year. Use them to accelerate hospital discharge of elderly or frail people into reablement by social services.
Overview of Innovation:



Kemuri K-Sockets are power sockets with multiple sensors that continuously measure:
  • Movement of people in the kitchen;
  • Electrical power for kettles, microwaves or toasters;
  • Room temperature;
  • Power supply.
They send data via the Internet via GSM mobile phone communications.  Kemuri software learns patterns of normal activity and analyses Activities of Daily Living (ADLs) every hour.  As soon as the system identifies too many changes from normal, it automatically alerts people who need to respond to possible risks.  Responders can be families, carers or 24/7 alarm response centres.

The WebApp gives evidence of reablement of the service users.  It gives confidence to responders who have been given informed consent to view the data.  For example:
  • Wandering or unattended falls: Kemuri alerts non-return to kitchen;
  • Nutrition & Hydration: Kemuri alerts risk of dehydration or malnutrition;
  • Engaged the Community: Kemuri apps are free to authorised family, carers or voluntary sector;
  • Active in the home: If people can eat, drink and move around in warm surroundings – then they are performing key ADLs.
Portable K-Sockets are allocated to discharge teams as part of the normal hospital discharge process. Families or other carers have to respond to alerts and determine the action to be taken.  The devices are re-allocated to patients every 6 weeks. Thereafter fixed K-Sockets can be installed in kitchens as wellbeing monitors. 



The cost is less than £500 per year, and the notional saving on bed days is approximately £400 per day.  By using a unit eight times per year, more than £3200 budget is released for more patients.  This represents more than 500% return on investment in one year.  This must be worth a trial in the region.  Additional benefit can come from reduced re-admissions.

Surrey County Council have awarded a grant of £50,000 for measuring the reablement process and subsequent wellbeing monitoring.
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Two areas of immediate benefit are the saving of excess bed days for non-medical reasons and the avoidance of re-admission. 
  • Many elderly and frail people cannot be safely discharged from hospital without a period of reablement by family members or professional domiciliary carers.  The NHS typically funds this for a maximum of six weeks – at lower cost than the occupation of a hospital bed.  After assessment and transfer of care to social services, continuous monitoring by K-Sockets permits safe discharges a day or more earlier.  This eases the problems of Bed Managers seeking to release beds for new patients.
  • During reablement, automatic alerts warn of unusual changes of activity.  They could indicate the risk of unattended falls, dehydration, malnutrition of hypothermia; all costly to the NHS.  Appropriate action could avoid the need for re-admission.  
Kemuri is designed for both family carers and 24/7 response services.  Portable K-Sockets require zero installation time and do not require broadband.  Monitoring and machine learning starts within minutes and any people with consent for data sharing can immediately view the data or receive alerts.
 
Longer-term benefits come from wellbeing monitoring after reablement.  Portable K-Sockets can be replaced by fixed K-Sockets.  The data analysis could reveal medical problems, such as UTIs, and preventive action could avoid more costly treatments.    
Initial Review Rating
3.00 (1 ratings)
Benefit to WM population:
Most older people want to return to their own homes as soon as possible after treatment.  Unfortunately, for some independent people, they cannot be discharged because there is no care provision at home.  Perhaps they have no local family or friends.  Consenting to reablement monitoring by K-Sockets could accelerate their discharge and improve health outcomes. 

Families also obtain peace of mind, whether they live locally or at great distances.  At any time of day, people can be alerted to possible problems and respond appropriately.  Most frequently it may only require a reassuring phone call.  On other occasions it could be an unattended fall or medical event that needs clinical action.  Earlier treatment leads to better health outcomes.

It may be possible to reduce the costs of domiciliary care with more-timely and less frequent visits. 
This is an example screen:


A green day shows normal activity.  An amber day shows more changes from normal activity – but may not be cause for alarm.  Red days are alerted during the day and are a call for action.  Viewers can drill down to more detail, and the screen below could indicate the risk of hypothermia.

K-Sockets are invaluable as passive monitors to supplement active telecare devices, such as pendant alarms.  The latter are not worn continuously by 90% of the people who have them and they need reasonable cognition to use them when necessary.  K-Sockets are not stigmatising and do not require any change of lifestyle.

For more information and downloads see http://www.kemurisense.com


 
Current and planned activity: 
Cornwall Council is trialling 20 portable K-Sockets for reablement.  In one case, an alert was sent to a family member before they knew about an unattended fall.
 
Surrey County Council have awarded a grant for TECS Innovation.  The plan is to supply 40 portable K-Sockets for reablement and then supply 100 fixed K-Socket to vulnerable people for six months.  Social Care will perform assessments as part of their normal case management.  An anonymised log of each service user should provide evidence of the bed days saved.  Statistics of readmission or transfer to full-time residential care can be compared to current averages.
 
Many K-Sockets are operational in small trials and some are still operational after years of use in private houses and housing association properties.  They could collect data for several years in long-term trials for clinical trials, such as for drugs for relieving the symptoms of dementia.
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 
 
Kemuri, KemuriSense, K-Sockets and K-Fobs are registered trademarks. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
K-Sockets can be produced in batches of 100 to 1000 from a factory in Woking.  If demand rises, second sourcing could be obtained in the WM region.
 
Web services are cloud-based and rapidly scaled at short notice.  Surrey has the largest scale implementation, which should peak at 140 units.  Scale-up should start by engaging with hospital discharge units and reablement teams.  Services to self-funders and Local Authorities can be scaled up by using the larger telecare service companies who provide other equipment and 24/7 call centres. 
Measures:
Quality
  • Alerting the risk of unattended falls, dehydration, malnutrition and hypothermia;
  • Continuous reliable operation
  • Avoidance of false alerts
  • Identifying unusual activity that may indicate need for medical intervention, eg for UTIs or TIAs.
 
Safety
  • Responding to alerts in time to minimise poor health outcomes;
  • Reduction in re-admissions.
 
Cost
The cost of deploying a portable K-Socket is less than £500 per year.  If this saves an average of one excess bed day per month, then the notional return on investment will more than 500%. 
 
People
The target service users are older people awaiting discharge from hospital who:
  • Need initial support from reablement teams;
  • Live independently and do not normally have daily visitors;
  • Can respond to phone calls;
Responders to alerts may be family members, carers or 24/7 response centres.
 
Ethics
Service users must give informed consent for data sharing with approved people such as practitioners, domiciliary cares and family members.
Adoption target:
West Midlands has a population of 5 million.  Engaging 1000 suitable service users per year is a reasonable target.  100 portable K-Sockets is a minimum viability level.  If successful, then growth to 10,000 service users is practical.   
Read more
Hide details
0
0
Votes
-99999

Created by

Share and Follow